RELATIONSHIP BETWEEN 1ST PHASE INSULIN-SECRETION AND AGE, HLA, ISLET CELL ANTIBODY STATUS, AND DEVELOPMENT OF TYPE-I DIABETES IN 220 JUVENILE 1ST-DEGREE RELATIVES OF DIABETIC-PATIENTS

Objective: To assess the adequacy of the first-phase insulin response for predicting development of insulin-dependent diabetes. Research Design and Methods: Determinations were made of 1- and 3-min insulin responses to glucose (0.5 g/kg i.v.), islet cell antibodies (ICAs), insulin autoantibodies (IAAs), and HLA. We studied 220 first-degree relatives (aged 3-29 yr) of diabetic patients; 75 underwent two or more tests. Results: At the first test, insulin responses correlated with age in ICA- children less-than-or-equal-to 11 yr old (r = 0.46, P < 0.001). Individual responses varied widely in all ages, and low values were common (5th percentile: 108 pM in children < 5 yr old, 180 pM thereafter). No correlation was found between insulin responses and IAAs or HLA. The responses of 15 ICA+ subjects were not significantly different from those of ICA- subjects after excluding the influence of age. At subsequent tests, ICA+ and ICA- subjects displayed distinct changes; the mean +/- SE insulin response increased in ICA- subjects from 619.2 +/- 40.8 to 716.4 +/- 50.4 pM (P < 0.001) but declined in ICA+ subjects from 403.2 +/- 91.8 to 313.8 +/- 67.2 pM (P < 0.02). During follow-up, 5 of 9 (56%) consistently ICA+ siblings developed diabetes or impaired glucose tolerance compared with 1 of 54 (2%) consistently ICA- subjects. The sensitivity and specificity of two or more low insulin responses (300 pM) for predicting progression to diabetes were 60 and 96%, respectively; the predictive value was 43%. The highest predictive value (75%) was achieved by the combination consistently ICA+, consistently low insulin response, and HLA-DR3/4. However, in no subject could the time of onset of diabetes be deduced from the decline of the insulin response. Conclusions: Consecutive intravenous glucose tolerance tests are a useful complement for predicting progression to diabetes but not its onset.